News about Global Pharma

Malaysia, Singapore Partner to Launch Medical Device Regulatory Reliance Pilot

The Medical Device Authority (MDA) of Malaysia and the Health Sciences Authority (HSA) of Singapore have signed a Memorandum of Understanding (MOU) to deepen regulatory cooperation and officially launched a 6-month pilot of the Medical Device Regulatory Reliance Programme.

Global Pharma | 26/08/2025 | By Dineshwori |  308

CuraTeQ Biologics Receives UK MHRA Approval for Trastuzumab Biosimilar Dazublys

CuraTeQ Biologics, a wholly owned step-down subsidiary of Aurobindo Pharma, has obtained marketing authorisation from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for its trastuzumab biosimilar, Dazublys.

Global Pharma | 26/08/2025 | By Dineshwori |  559

MannKind to Acquire scPharmaceuticals, Expanding into Cardiorenal Medicine

MannKind’s acquisition of scPharmaceuticals is expected to be completed in the fourth quarter of 2025.

Global Pharma | 25/08/2025 | By Dineshwori |  248

GSK Enters Oncology in India with Launch of Jemperli and Zejula for Gynaecological Cancers

GSK has launched its much-awaited advanced therapies Jemperli (dostarlimab) and Zejula (niraparib) in India, reinforcing its commitment to addressing the unmet need for gynaecological cancers in the country.

Global Pharma | 25/08/2025 | By Dineshwori |  336

Bio-Thera, STADA Expand Biosimilars Alliance to Include Tocilizumab

Bio-Thera Solutions and STADA Arzneimittel have extended their biosimilars alliance to include tocilizumab, with Bio-Thera handling development and supply while STADA secures exclusive commercialization rights across Europe and select markets.

Global Pharma | 25/08/2025 | By Mrinmoy Dey |  250

Collaboration is Key to Resilient Medical Device Ecosystem: Pharma Secretary

Amit Agrawal, Secretary of the Department of Pharmaceuticals, has emphasised the need to strengthen the medical device sector ecosystem not only through technology and skilled manpower, but also by establishing “internationally accredited laboratories, adopting globally harmonised standards and supporting clinical investigations for innovative devices.”

Global Pharma | 25/08/2025 | By Dineshwori |  141

Akums to Set Up Manufacturing Facility in Zambia

Akums Drugs and Pharmaceuticals has signed a framework agreement with the Government of the Republic of Zambia to establish a local manufacturing facility in the country and supply essential medicines.

Global Pharma | 25/08/2025 | By Dineshwori |  342

Gyre Therapeutics Appoints Dan Weng to Board of Directors

Gyre Therapeutics, a US-based commercial-stage biopharmaceutical company focused on innovative therapies for organ fibrosis, has announced the appointment of Dr. Dan Weng, former CEO of Medelis, to its Board of Directors.

Global Pharma | 22/08/2025 | By Dineshwori |  228

ANGLE Forms Strategic Collaboration with Myriad Genetics

ANGLE plc has entered into a collaboration with Myriad Genetics to evaluate circulating tumour cell DNA using ANGLE’s Parsortix system alongside Myriad’s tissue-based assays, aiming to advance precision oncology.

Global Pharma | 22/08/2025 | By Mrinmoy Dey |  153

Alvotech and Advanz Pharma Secure European Approval for Eylea Biosimilar Mynzepli

Alvotech and its commercial partner Advanz Pharma have announced that the European Commission has granted marketing authorisation for Mynzepli (aflibercept), a biosimilar to Eylea, available in both pre-filled syringes and vials.

Global Pharma | 22/08/2025 | By Dineshwori |  222